Kevin Strange Ending Age Related Diseases 2019
We are continuing to release the talks from Ending Age Related Diseases 2019, a highly successful two-day event that brought together leading researchers and investors to discuss the future aging and rejuvenation.
Kevin Strange talked about his company Novo Biosciences and how they are developing small molecules to restore the body’s regeneration ability. He explained how this ability is present at birth but diminishes as we age. He talked about MSI-1436 which is a potential drug to reverse ischemic injury, make life easier for heart attack survivors and reverse skeletal muscle degradation.
Source:
https://www.leafscience.org/kevin-strange-at-ending-age-related-diseases-2019/
